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Bone morphogenetic proteinThe actin cytoskeleton inside extending axonal and dendritic processes must undergo continuous assembly
and disassembly. Some extrinsic factors modulate actin turnover through controlling the activity of LIM
kinase 1 (LIMK1), which phosphorylates and inactivates the actin depolymerizing factor coﬁlin. Here, we for
the ﬁrst time examine the function and regulation of LIMK1 in vivo in the vertebrate nervous system. Upon
expression of wildtype or kinase-dead forms of the protein, dendrite growth by Xenopus retinal ganglion
cells (RGCs) was unchanged. In contrast, maintaining a low, but signiﬁcant level, of LIMK1 function in the
RGC axon is critical for proper extension. Interestingly, bone morphogenetic protein receptor II (BMPRII) is a
major regulator of LIMK1 in extending RGC axons, as expression of a BMPRII lacking the LIMK1 binding
region caused a dramatic shortening of the axons. Previously, we found that BMPRIIs stimulate dendrite
initiation in vivo. Thus, the fact that manipulation of LIMK1 activity failed to alter dendrite growth suggests
that BMPs may activate distinct signalling pathways in axons and dendrites.
© 2009 Elsevier Inc. All rights reserved.Introduction
Retinal ganglion cells (RGCs) are the output neurons of the eye,
receiving visual signals from the retina to then transmit to the brain.
We and others have previously characterized some of the extrinsic
factors important for the morphological development of RGCs, i.e. for
the elaboration of a complex dendritic arbor and the extension/
guidance of a long axon, followed by integration into the proper neural
circuits (Erskine and Herrera, 2007; Hocking et al., 2008; Parrish et al.,
2007; Sernagor et al., 2001). Yet, intrinsic factors also play a large role
in the development of neuronal morphology. For example, the level of
cyclic nucleotides can determine a growth cone's response to a
guidance cue (Song et al., 1998). While the intracellular factors that
modify the neuronal cytoskeleton in response to extracellular cues are
beginning to be elucidated (Kalil and Dent, 2005), whether different
signalling pathways mediate the responses of axons and dendrites to
the same extracellular cues is not known.
One factor implicated in regulating the axonal and dendritic
outgrowth of neurons in vitro is the cytoplasmic kinase LIM kinase 1
(LIMK1) (Endo et al., 2003; Hsieh et al., 2006; Lee-Hoeﬂich et al.,
2004; Mizuno et al., 1994; Rosso et al., 2004; Tursun et al., 2005). TheC 2207, University of Calgary,
.
l rights reserved.LIMK1 and LIMK2 proteins are ubiquitously expressed, though LIMK1
is particularly enriched in the brain as well as in the growth cones of
cultured neurons (Acevedo et al., 2006; Foletta et al., 2004; Piper et al.,
2006; Rosso et al., 2004). LIMK1 directly impacts the assembly of actin
ﬁlaments in response to modulation of its activity by extrinsic signals
(Sarmiere and Bamburg, 2004; Takahashi et al., 2003). Importantly,
the addition of actin monomers to the fast-growing barbed ends of
ﬁlamentous actin (F-actin) is thought to provide the framework
needed to push the membrane forward and extend a lamellipodia or
ﬁlopodia (Sarmiere and Bamburg, 2004). LIMK1 phosphorylates and
inactivates the actin depolymerizing factors ADF and coﬁlin1/2
(referred to collectively as coﬁlin throughout). Coﬁlin regulates actin
dynamics by removing actin monomers from the slow-growing
pointed ends of F-actin, or by severing actin ﬁlaments (Sarmiere
and Bamburg, 2004). Coﬁlin activity maintains a balance in cytoske-
letal dynamics, both breaking down actin ﬁlaments where these are
no longer needed and promoting ﬁlament growth. Interestingly, while
coﬁlin, a crucial regulator of actin dynamics, is downstream of LIMK1,
Rho GTPases, which are major players in axon and dendrite growth,
act upstream of LIMK1 (Govek et al., 2005; Ruchhoeft et al., 1999).
p21-activated kinase (PAK) and Rho-associated coiled-coil domain
kinase (ROCK) are downstream effectors of Cdc42/Rac1 and RhoA,
respectively, and both can activate LIMK1 through phosphorylation
(Bernard, 2007).
The function of LIMK1 in process outgrowth has been investigated
mainly in axons growing in vitro, in which the manipulation of LIMK
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motility, apparently dependent on cell type and culture conditions
(Endo et al., 2003; Rosso et al., 2004; Tursun et al., 2005). In vivo, we
know only that overexpression and loss-of-function of LIMK in the
mushroom body neurons of Drosophila each caused axon stalling and
guidance errors (Ng and Luo, 2004). The involvement of LIMK1 in
dendrite development is even less clear, although LIMK1 is expressed
in dendritic growth cones (Lee-Hoeﬂich et al., 2004; Tursun et al.,
2005). While hippocampal neurons in mice mutant for limk1 do have
impaired dendritic spine morphology and synaptic function, their
dendritic arbors appeared to develop normally (Meng et al., 2002).
Yet, in vitro experiments showed that LIMK1 interacts directly with
the cytoplasmic tail of BMP receptor II (BMPRII) (Foletta et al., 2003),
and mediates BMP-induced dendrite outgrowth of cortical neurons
(Lee-Hoeﬂich et al., 2004). More recent work showed that the
attraction of Xenopus spinal neuron axons to BMP7 in culture is also
mediated by BMPRII and LIMK1 (Wen et al., 2007). Whether LIMK1
functions in the formation of vertebrate neuronal processes in vivo,
either in response to BMP signalling or other extrinsic signals, remains
largely unknown.
In this study, we investigate a role for LIMK1 in both axon and
dendrite outgrowth of Xenopus RGCs in vivo. We show that limk1 is
expressed by these cells at the time of process outgrowth, and that it
has a speciﬁc function in the morphological development of their
axons. Dendrite initiation, growth, and branching were unaffected by
overexpression of either wild type (wt) or kinase-dead (kd) LIMK1
within developing RGCs. RGC axon growth, however, requires tight
control of the levels of LIMK activity as extension defects were
observed with overexpression of wtLIMK1, kdLIMK1 and slingshot
phosphatase, a negative regulator of LIMK1. Interestingly, a BMP
receptor II (BMPRII) lacking the LIMK-binding region, but not the
wildtype BMPRII, causes a similar shortening of axons, suggesting that
BMPs in the brain signal through LIMK to promote RGC axon
outgrowth. Since we found previously that BMP signalling promotes
RGC dendrite initiation in vivo (Hocking et al., 2008), these data argue
that LIMK1 function is necessary downstream of BMP receptor
activation in axons, but not dendrites, indicating that distinct signal
transduction mechanisms may act downstream of a receptor
expressed in both axons and dendrites.
Experimental procedures
Animals
Xenopus laevis embryos were obtained by in vitro fertilization of
eggs produced by females who had been primed with human
chorionic gonadotrophin (Chorulon; Intervet). Embryos were reared
in 0.1×Marc's Modiﬁed Ringer's solution (MMR; 0.1 M NaCl, 2 mM
KCl, 1 mM MgCl2, 5 mM HEPES, pH 7.5) at 14–25 °C and staged
according to a standard set of criteria (Nieuwkoop and Faber, 1994).
Expression constructs
Xenopus lim kinase 1 (limk1) constructs, both a wildtype (wtlimk1)
and a kinase-dead version with a D435N mutation (kdlimk1)
(Takahashi et al., 1997, 2001) were subcloned into the CS2-MT
expression vector, with the myc tag at the 5′ end.
cDNA encoding a full-length Xenopus BMP receptor II (dnBMPRII)
in the vector pCS2-ITR was obtained from Dr. Sylvia Evans (University
of California at San Diego) (Shi et al., 2000). A dominant negative
BMPRII construct that lacks the LIMK-binding region (BMPRIIΔLBR),
but still has the kinase domain, was generated from the full-length
BMPRII by designing PCR primers to amplify the entire coding
sequence with the exception of 888 nucleotides at the 3′ end of the
gene (full coding sequence is 3.1 kb). The primers used were
BMPRI ILBR_for: ATCGATCTCCTATGGTATTCTTGCTTATTCC,BMPRIILBR_rev: ATCGATGAACATCCTGGACAATGCAAGC. The domi-
nant negative receptor was subcloned into CS2-MT such that a myc
tag was added to the carboxyl terminus of the protein. A CS2 construct
encoding green ﬂuorescent protein (CS2-GFP) was used alone as a
control in all experiments, and was co-injected with the experimental
constructs to help screen for expressing embryos and for the analysis
of cell morphology.
Transgene expression
The lipofection method used to create mosaic gene expression by
injection of a mixture of a transfection agent (DOTAP) and cDNA
constructs into the presumptive eye region of stage 19 Xenopus
embryos has been described previously (Holt et al., 1990). Alterna-
tively, electroporation was used as described (Chen et al., 2007) to
target either the eye or brain of anaesthetized stage 27 embryos.
Following gene transfer, embryos developed at room temperature in
0.1×MMR until stage 40, and were then ﬁxed overnight at 4 °C in 4%
paraformaldehyde and processed for wholemount or section
immunochemistry.
Antibodies
Antibodies used include the following: anti-myc [9E10; Develop-
mental Studies Hybridoma Bank (DHSB); 1:500], rabbit or mouse
anti-GFP (Invitrogen; 1:500), rabbit anti-myc (Santa Cruz; 1:500),
mouse anti-hemagglutinin (HA; Covance; 1:500), rabbit anti-HA
(Covance; 1:500), rabbit anti-phosphocoﬁlin1 (P-coﬁlin1; Santa Cruz;
1:3000), rabbit anti-phosphocoﬁlin2 (Abcam; 1:100), and rabbit anti-
phosphoLIMK1/2 (P-LIMK; Novus Biologicals; 1:50–1:150). Second-
ary antibodies included goat anti-mouse and anti-rabbit antibodies
conjugated to peroxidase (1:500) or AMCA (1:250) from Jackson
ImmunoResearch Laboratories Inc., and goat anti-mouse and goat
anti-rabbit antibodies conjugated to Alexa 546 (1:1000) or Alexa 488
(1:1000) (Invitrogen).
Immunochemistry
Immunochemistry was performed on tissue sections, and whole
embryos as previously described (Cornel and Holt, 1992; McFarlane et
al., 1995). For tissue sections, ﬁxed embryos were immersed in 30%
sucrose in PBS prior to embedding in Optimal Cutting Temperature
compound (OCT, Baxter) and quick freezing. Twelve micrometer
transverse sections were cut on a cryostat (Leica) and collected on
gelatin-coated slides. Slides or partially dissected embryos were
incubated in primary antibodies diluted in PBT [PBS with 0.5% Triton
(BDH) and 0.2% BSA] containing 5% goat serum (Invitrogen) for 1 to
3 h at room temperature or overnight at 4 °C. Samples were rinsed,
and then in the case of slides, secondary antibodies conjugated to
ﬂuorescent tags and diluted 1:250–1:1000 in PBT-goat serum were
added for 1 h. Slides were mounted in the antibleaching agent
Polyaquamount (Polysciences Inc.). In contrast, immunolabelling in
the wholemount brains was visualized with a peroxidase-conjugated
secondary antibody followed by reaction with diamino benzidine
(DAB; Sigma-Aldrich Co.). Anterograde axon labelling with horse-
radish peroxidasewas performed as described (Chien et al., 1993), and
brains were dissected prior to the DAB reaction. Brains were then
removed and dehydrated in serial ethanol washes, cleared in xylene
and mounted in Permount (Fisher Scientiﬁc Company) under cover-
slips supported with two plastic reinforcement rings.
Dendrite analysis
In vivo, RGCs were identiﬁed based on the location of the cell body
in the ganglion cell layer of the retina. Dendritic arbors were assessed
at stage 39/40, when the arbor is still relatively simple: on average
Fig. 1. Expression of limk1 in the developing Xenopus retina. (A–F) Xenopus embryos
processed for wholemount in situ hybridization using antisense RNA probe for limk1.
Whole embryos show a restricted pattern of limk1 expression. The eye, otic vesicle,
areas of the brain and the nasal placodes all express limk1 mRNA at stage 30 (A). The
pattern is maintained, but stronger in the eye and brain, at stage 35/36 (B). Transverse
vibratome sections through labelled embryos shows the changing pattern of limk1 in
the retina. At stage 28, the optic vesicle has not yet invaginated and there is a patch of
limk1 expression in the dorsal/central retina that spans the width of the tissue (C). By
stage 30, the optic cup is present and limk1 is expressed in the inner layers that will
become the GCL (⁎⁎) and the inner nuclear layer (INL) (not labelled) (D). Expression
has spread to the dorsal ciliary marginal zone (CMZ; white arrowhead), but is still
absent from the ventral CMZ (black arrowhead). Expression in the central retina has
weakened slightly at stage 33/34 (E), while the dorsal CMZ, ventral retina and ventral
CMZ show robust expression. The divisions between the emerging layers are shown by
the white lines in E (from lens outward is GCL, INL, ONL). limk1 expression in RGCs
begins to decrease at stage 35/36 (F), but is still strong in the INL and CMZ. A, anterior;
br, brain; D, dorsal; e, eye; np, nasal placodes; nr, neural retina; ot, otic vesicle; P,
posterior; V, ventral. Scale bar in C is 50 μm.
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points (Fig. 5). As such, the entire arbor can be captured by using
standard ﬂuorescence microscopy (generally 1–3 images in slightly
different focal planes were sufﬁcient to capture the entire dendritic
arbor). A number of dendritic parameters were measured, including:
1) the number of primary dendrites/cell (processes that extended
directly from the cell soma and grew towards the inner plexiform
layer (IPL)), 2) the width of the arbor parallel to the IPL at the
location of the cell body, 3) the total dendrite length (i.e. the lengths
of all the branches and the primary dendrites), and 4) the number of
branch points as deﬁned by any site where a dendrite split to produce
two or more branches. Statistical analysis was performed with Sigma
Stat (Systat Software, Inc.) and is described in ﬁgure legends.
cDNA templates and riboprobe synthesis for in situ hybridization
Antisense riboprobes were synthesized using T7, T3, or SP6 RNA
polymerases (Promega), digoxygenin- (DIG; Roche) or dinitrophenyl-
(DNP; Perkin Elmer) labelled nucleotides, and linearized Xenopus
laevis cDNA templates. The limk1 probe was made from full-length
cDNA (NM_001087708). The full-length bmp2 (X55031), and bmp4
(AJ005076) were kind gifts from A.H. Brivanlou (Rockefeller Uni-
versity, New York). From Open Biosystems (www.openbiosystems.
com), we obtained IMAGE clones for two gdf11 ESTs [BJ089460 (3′
end), BJ072431 (5′ end)] and a full-length bmp7 (BC055959).
Wholemount in situ hybridization
In situ hybridization was performed as described previously
(Harland, 1991), with minor modiﬁcations. Embryos were incubated
overnight at 60 °C in hybridization buffer [50% formamide (Fluka),
5×SSC (0.75M sodium chloride, 75mM sodium citrate, pH 7.0),1mg/
mL Torula RNA (type IX, Sigma-Aldrich Co.), 0.1% Tween-20 (Sigma-
Aldrich Co.), 10 mM EDTA (BDH), and 1×Denhart's solution (0.02%
BSA, 0.02% polyvinylpyrrolidone, 0.02% Ficoll, all from Sigma-Aldrich
Co)] containing approximately 0.5 μg/mL of DIG- or DNP-labelled RNA
antisense probe. After washing, another overnight incubation was
performed, this time in a blocking solution of 2% blocking reagent
(Roche) in maleic acid buffer [MAB; 100 mM maleic acid (Sigma-
Aldrich Co.), 150 mM sodium chloride, pH 7.5] with alkaline
phosphatase-conjugated anti-DIG (Roche; 1:2000) or anti-DNP anti-
body (Mirus Bio Corporation; 1:1000). Following washes in MAB, the
chromogenic reaction was performed using the substrate BM purple
(Roche). Finally, the embryos were ﬁxed in 9% formaldehyde (BDH)
with 5% glacial acetic acid (BDH). The endogenous pigment was
removed by treatment with a bleaching solution [1% hydrogen
peroxide, 5% formamide (Fluka), 0.5×SSC] during exposure to
ﬂuorescent light. Some of the embryos were cut into thick 50 μm
vibratome sections with a Leica VT1000S vibratome (Leica) following
in situ hybridization.
Prepared samples were visualized with Zeiss microscopes and
photographed with either a SPOTII camera and SPOT Advanced
software (Diagnostic Instruments), or a Zeiss AxioCam MRm camera
and Axiovision 3.1 software, and later processed for contrast and
brightness with Adobe Photoshop CS2. Confocal images shown are
stacked images of 1 μm optical sections taken on an Olympus laser-
scanning microscope.
Results
limk1 mRNA is expressed in the developing Xenopus retina
The X. laevis limk1 gene was isolated previously and found to be
expressed in the eyes and regions of the head (Takahashi et al., 1997).
To examine the temporal and spatial expression pattern of limk1 in the
developing retina, we performed in situ hybridization onwholemountXenopus embryos using antisense limk1 riboprobe at the stages when
RGCs extend neurites. RGCs are born at stage 24 (24 h) and the ﬁrst
cells initiate an axon at stage 28 (Holt, 1989). After leaving the eye,
the axons cross to the contralateral side of the brain at the optic
chiasm beginning at stage 32 (48 h), and then enter the part of the
pathway known as the optic tract. The axons of the optic tract travel
through the diencephalon to reach their target, the tectum, by stage
40 (72 h). RGC dendrites, meanwhile, are initiated starting at stage
30/31, grow into the inner plexiform layer (IPL) to make contacts
with retinal interneurons, and continue to increase in complexity
and undergo targeting reﬁnements long past stage 40 (Holt, 1989;
Lom et al., 2002).
Signiﬁcant limk1mRNA expression is limited to only a few regions
of the embryo, including the eye primordia, nasal placodes, otic
vesicle, and parts of the brain (Figs. 1A, B, data not shown). This
pattern is consistent from stages 28–37/38. In 50 μm transverse
vibratome sections, strong expression is evident in the retina (Figs.
276 J.C. Hocking et al. / Developmental Biology 330 (2009) 273–2851C–F). In a stage 28 embryo, prior to invagination of the eye, limk1
label appears as a dark patch in the dorsal/central optic vesicle (Fig.
1C). Starting at stage 30 (Fig. 1D), and lasting through the period of
limk1 expression (Figs. 1E, F), the label is strongest in the developing
ganglion cell layer (GCL; marked by “⁎⁎”) and inner nuclear layer
(INL), and weakest in the outer-most cells, which become the
photoreceptors of the outer nuclear layer (ONL). The proliferative
ciliary marginal zone (CMZ) appears as distinct dorsal and ventral
regions in transverse sections. At stage 30, limk1 expression has
extended to the dorsal CMZ, but is excluded from the ventral CMZ (Fig.
1D). limk1 expression in RGCs begins to decrease at stage 35/36 (Fig.
1F), and by stage 37/38 the label is signiﬁcantly diminishedwithin the
postmitotic retina (data not shown). In summary, limk1 is expressed
by RGCs from stage 28 to stage 35/36, which is during themain period
of axon outgrowth and the early stages of dendrite development. Of
note, LIMK1 protein is reported to have a long half-life (∼20 h) (Li et
al., 2006), and so is likely to last considerably longer than the mRNA
expression.
Phospho-LIMK1 is expressed by RGC axons and in the inner plexiform
layer where RGC dendrites form synaptic connections
Since RGCs express limk1mRNA, we needed next to determine the
subcellular localization of LIMK1 protein, and whether the active
Thr508 phosphorylated form of the kinase (Bernard, 2007) is present
in RGC dendrites and/or axons. To do so, transverse cryosections of
stage 33/34 to 37/38 embryos were labelled with antibodies that
detect phosphoLIMK1/2 (P-LIMK). This antibody recognizes a single
band of the appropriate size in a Western of Xenopus tissue (Fig. 2A)
(Takahashi et al., 2001). At stage 33/34, when RGCs are actively
extending processes, P-LIMK labelling is present in RGC axons as they
travel across the vitreal surface of the retina and form the optic nerve
head that exits the eye (Fig. 2B). The optic nerve just prior to entering
the brain and the brain neuropil are also P-LIMK immunoreactive (Fig.
2C). By stage 35/36, central retinal sections show some labelling in the
forming inner plexiform layer to which RGC dendrites project (data
not shown). Shortly after, at stage 37/38, P-LIMK immunoreactivity
within the retina resolves to the ﬁber layers, including the optic nerve
head, the vitreal surface of the retina and the IPL (Fig. 2D). InFig. 2. LIMK is active in developing RGCs and their processes. (A) The P-LIMK antibody detec
(B–D) Transverse cryosections were immunolabelled with the antibody, and stacked optical s
RGC axons run along the vitreal surface of the retina (arrows) and in the optic nerve head, and
ventral diencephalon (white arrowheads). Labelling of the brain neuropil is also evident. At s
is now more obvious labelling of the IPL. cmz, ciliary marginal zone; Di, diencephalon; D, do
RGCL, retinal ganglion cell layer; V, ventral.summary, the LIMK pathway is active in developing RGC axons and
possibly their dendrites.
The downstream target of LIMK, P-coﬁlin, is expressed by RGCs
The only known targets for LIMK activity are the proteins of the
coﬁlin family (Bernard, 2007). In mouse, coﬁlin1 is expressed
ubiquitously, while coﬁlin2 and ADF have more deﬁned patterns
(Vartiainen et al., 2002). We labelled cryostat sections of Xenopus
embryos at various stages with an anti-P-coﬁlin1 antibody that gave
speciﬁc labelling on a Western blot of a protein at approximately the
expected size of 21 kDa (Fig. 3). As with mouse, the active proteinwas
expressed throughout the embryo, exhibiting a much broader
expression pattern than P-LIMK1 (Figs. 3A, B). Interestingly, the
intensity of staining is heterogeneous, with many RGC somata
exhibiting a relatively high level of P-coﬁlin1 from stages 33/34 to
40. However, little or no optic nerve or IPL label was observed. Of note,
a previous study showed that P-coﬁlin1 is present in the growth cones
of cultured Xenopus RGC axons (Piper et al., 2006). Our data using a P-
coﬁlin2 antibody hint that coﬁlin2 (Vartiainen et al., 2002) is also
expressed in RGCs and their processes between stages 33/34 and 40
(data not shown). While the P-coﬁlin2 antibody detected, in addition
to the expected 21 kDa band, a number of non-speciﬁc bands on
Western blots, the similarity to the P-LIMK expression pattern
suggests that the antibody detects a P-coﬁlin protein in situ. These
data argue that the downstream coﬁlin targets of LIMK1 are present in
their phosphorylated form in RGCs and their axons.
Regulation of LIMK1 activity is not required for RGC dendritogenesis
LIMK1 activation is necessary for the enhanced dendrite growth of
cultured cortical neurons in response to BMP treatment (Lee-Hoeﬂich
et al., 2004). Since we showed previously that BMP signalling is
sufﬁcient and necessary, together with Activin receptor signalling, to
promote primary dendritogenesis by RGCs (Hocking et al., 2008), we
expected LIMK1 to be an element in the pathway downstream of BMP
receptor activation in vivo. Therefore, we tested the in vivo role of
LIMK1 in dendrite growth, hypothesizing that it is involved in RGC
dendrite initiation.ts the phosphorylated, active forms of LIMK1/2 with the molecular weight of ∼65 kDa.
lices presented. At stage 33/34, there is label in RGC axons, shown in a section (B) where
in a section (C) that has captured part of the bilateral optic nerves before they enter the
tage 37/38 (D), the optic ﬁber layer expression is still present (white arrows), but there
rsal; IPL, inner plexiform layer; L, lens; onh, optic nerve head; PE, pigment epithelium;
Fig. 3. P-coﬁlin1 is expressed by RGCs. In the top left is aWestern blot of protein isolated from stage 37/38 embryos, labelled with an antibody that recognizes P-coﬁlin1. The antibody
recognizes a band at approximately 21 kDa (black arrow). (A, B) Transverse cryosections of Xenopus embryos immunolabelled with the P-coﬁlin1 antibody. P-coﬁlin1 is expressed in
the retina at stage 33/34, particularly in a subset of cells in the GCL (⁎⁎; A). In a lower power view of a labelled section through the eyes and brain of a stage 35/36 embryo, we can
see that Pcoﬁlin1 is expressed throughout the embryo, but at variable levels (B). Scale bar is 50 μm in A for A. Scale bar in B is 25 μm. br, brain; D, dorsal; L, lens; nr, neural retina;
V, ventral.
277J.C. Hocking et al. / Developmental Biology 330 (2009) 273–285In order to manipulate the activity of LIMK1, Xenopus wild type
(wt) and kinase-dead (kd) LIMK1 constructs (Takahashi et al., 1997,
2001) were subcloned into a CS2 expression vector that adds amyc tag
(MT) for visualization of the transgenic protein. Efﬁcacy of the
constructs was tested by electroporation of each into the brains of
stage 27 Xenopus embryos, followed by ﬁxation, cryostat sectioning,
and immunolabelling for P-coﬁlin1 and myc. Transgene-expressing
cells within the diencephalonwere assessed for brightness of P-coﬁlin
label in a blinded fashion on a scale from 0–3. To control for variations
in ﬂuorescence intensity between slides, both myc+ and myc− GFP-
expressing cells were evaluated in the same brain sections. As
expected, cells expressing the wtLIMK1 construct exhibited an
increase in P-coﬁlin1 levels in comparison to neighboring cells (Figs.
4A, B, E) (Endo et al., 2003; Lee-Hoeﬂich et al., 2004; Rosso et al.,
2004; Takahashi et al., 2001; Yang et al., 2004). While kdLIMK1
expression did not result in an increase in the P-coﬁlin1 staining (Figs.
4B, D, E), we were also unable to detect a decrease in brightness
compared to neighboring cells. However, small decreases in label
would be difﬁcult to assess in this assay, as would be changes
restricted to speciﬁc subcellular regions. Signiﬁcantly, a similar
mutated LIMK1 was shown to completely abrogate BMP-induced
dendrite growth in cultured cortical neurons and axon turning in
Xenopus spinal neurons (Lee-Hoeﬂich et al., 2004; Wen et al., 2007).Fig. 4. wtLIMK1 increases the phosphorylation of coﬁlin. Stage 27 embryos were electropo
sectioned and immunolabelled for P-coﬁlin1. (A, C) Merged images of myc-expressing dien
kdLIMK1-electroporated (C) embryos. The matching images of P-coﬁlin expression alone a
intensity of P-coﬁlin1 expression in myc+ and myc− GFP-expressing cells was scored in a b
intensity between myc+ and myc− GFP-expressing cells for each condition. Only for wtLI
compared to the myc− cells.As such, these constructs were used to examine the function of LIMK1
in the development of RGC axons and dendrites.
In vivo expression of wtLIMK1-MT or kdLIMK1-MT was achieved
by lipofection into the developing retinal primordia of stage 19 Xe-
nopus embryos. Each construct was co-injected with CS2-GFP, and
CS2-GFP was injected alone as a control. First, embryos were
processed for wholemount immunolabelling at stage 40 with
antibodies against GFP or myc, and 50 μm vibratome transverse
vibratome sections were cut. The dendritic arbors at stage 40 were
fairly simple, and were not obviously different between control GFP
and LIMK transgenes (Figs. 5A–C). For quantitative analysis, it was
important to conﬁrm that the myc-tagged proteins were distributed
throughout the entire dendritic arbor. Thus, transfected embryos were
cut into 12 μm transverse cryostat sections. The GFP ﬂuorescence ﬁlls
the cell and sowas used to visualize morphology and analyze dendrite
formation, while immunolabelling for the myc-tagged constructs was
used to ensure that only cells expressing wtLIMK1 or kdLIMK1 were
analyzed (Figs. 5D–F). Importantly, both LIMK1 transgenic proteins
were transported into the dendrites of RGCs, as well as being found in
the somata and axons (Figs. 5D–F). The dendrites of transgene-
expressing RGCs in each condition were evaluated by assessing the
number of primary dendrites, thewidth of the arbor across the IPL, the
number of branch points, and the total dendritic length (Figs. 5G–J).rated with GFP and either wtLIMK1-MT or kdLIMK1-MT, ﬁxed at stage 37/38, cryostat
cephalic cells in blue (arrows) and P-coﬁlin1 expression in red, for wtLIMK1- (A) and
re also shown for each condition (B: wtLIMK1, D: kdLIMK1). Scale bar is 10 μm. The
linded fashion on a scale of 0–3. (E) Graph showing the ratio of the average P-coﬁlin1
MK1-expressing cells was there an increase in P-coﬁlin1 expression in the myc+ cells
Fig. 5. Changes to LIMK1 activity do not alter RGC dendrite growth and branching. CS2-GFP was transfected alone as a control, or with CS2-wtLIMK1-MTor CS2-kdLIMK1-MT, into the
retinal primordia of stage 19 Xenopus embryos. Embryos were ﬁxed at stage 40, and either vibratome (A–C) or cryostat sectioned (D–F), and expression of the myc-tagged LIMK1
constructs was detected by anti-myc immunohistochemistry. GFP ﬂuorescence ﬁlls the cell and allows for the analysis of cell morphology. Scale bar is 10 μm. Stars indicate branch
points. (A–C) RGCs in retinal vibratome sections expressing GFP alone (A), wtLIMK1 (B), or kdLIMK1 (C). (D–F) RGCs in cryostat sections expressing GFP alone (D), GFP plus kdLIMK1
(E), or GFP plus wtLIMK1 (F). GFP ﬂuorescence is shown in green, themyc-immunolabelling in red, and the merge in yellow. (G–J) Graphs showing the quantiﬁcation of the effects of
wtLIMK1 and kdLIMK1 on RGC dendrite development. The average number of primary dendrites (G), number of branch points (H), total dendritic length (I), and width of the
dendritic arbor (J) were similar in all conditions. n=the number of independent experiments, and in brackets are the numbers of cells analyzed for each condition. Error bars
are S.E.M. pN0.05, One Way ANOVA.
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RGCs expressing wtLIMK1, kdLIMK1, or GFP (pN0.05, One Way
ANOVA). Thus, we conclude that the formation of RGC dendrites is
not sensitive to alterations in LIMK1 activity.
Regulation of LIMK1 is required for proper axon outgrowth
Since RGCs do express limk1mRNA and P-LIMK protein, but LIMK1
does not appear to play a role in dendritogenesis, we next asked if
LIMK1 activity is important for RGC axon development. Indeed, as
shown above, activated LIMK1 protein could be detected in extendingaxons. To ask what role LIMK1 activity has in axon outgrowth in vivo,
the different forms of LIMK1 were misexpressed in a subset of RGC
axons growing towards the optic tectum. Transgene expression was
achieved by electroporation of CS2-GFP alone, or CS2-GFP together
with CS2-wtLIMK1-MT or CS2-kdLIMK1-MT, into the retinas of stage
27 Xenopus embryos. For the dendrite analysis, it was preferable to
target transgene expression to only a few transgenic RGCs per retina to
prevent confusion from overlapping dendritic arbors; however, for the
axon analysis we used eye electroporation to generate higher numbers
of transgene-expressing RGCs. At stage 40, embryos were ﬁxed and
their brains removed and immunostained as wholemounts using an
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GFP antibody for the control embryos. We used a peroxidase-
conjugated secondary antibody followed by a DAB reaction: thus,
transgene-expressing axons were labelled with a brown reaction
product.
The brains with labelled RGC axons were blinded and analyzed for
defects in axon growth or pathﬁnding. By stage 40, themajority of RGC
axons have reached the tectum in wild type embryos (Holt, 1989).
Although thiswas the case for axons expressingGFP alone (Figs. 6A–B),
wtLIMK1 caused an obvious problem in axon extension: RGC growth
cones were distributed at various earlier locations within the optic
tract (Figs. 6C–D). Indeed, signiﬁcantly fewer wtLIMK1-expressing
axonsmade it to the tectum than in control (Fig. 6G; pb0.001, OneWay
ANOVA, Student–Newman–Keuls post hoc test). Expression of the
kdLIMK1 (Figs. 6E, F) did not produce as dramatic a phenotype as the
wtLIMK1, and in fact many of the kdLIMK1-expressing RGC axons
extended normally (Fig. 6F). However, a signiﬁcant number of axons
from eyes electroporated with kdLIMK1 did fail to reach the tectum by
stage 40 (Figs. 6E, F, G; pb0.05; One Way ANOVA, Student–Newman–
Keuls post hoc test).
We used an alternate approach to inhibit the downstream effect of
LIMK1 pathway activation (coﬁlin phosphorylation) to help conﬁrm
the speciﬁcity of the axon extension defects observed with the
kdLIMK1. Slingshot phosphatases (SSH) dephosphorylate coﬁlin and
oppose LIMK1 inhibition of coﬁlin activity (Niwa et al., 2002; Endo et
al., 2003), and the response of growth cones of Xenopus spinal cord
neurons to BMP7 depends on a balancing act of the activity of LIMK1
and SSH pathways (Wen et al., 2007). Thus, we overexpressed wtSSH
in Xenopus RGCs. Retinal cells overexpressing wtSSH showed reduced
levels of P-coﬁlin1 immunoreactivity as compared to control GFP-
expressing cells (data not shown). In addition, similar to what was
observed with kdLIMK1, wtSSH-expressing RGC axons examined in
stage 39/40 brains were shorter in length than control and many
had not reached the optic tectum (GFP, 82.2±3.2% (S.E.M.) axons
in tectum, n=4 independent experiments (740 axons); wtSSH,
59.7%±11.2% (S.E.M.), n=4 (435 axons)).
Interestingly, expression of the LIMK1 constructs and wtSSH did
not appear to cause any gross errors in axon pathﬁnding. As the optic
tract travels from the optic chiasm to the tectum, it makes a
characteristic caudal turn in the mid-diencephalon. Potentially, the
shorter axons observed with misexpression of the LIMK1 transgenes
were axons that had failed tomake the appropriate guidance decisions
at this turn and consequently stalled. To test this idea, we determined
the location within the optic pathway of the growth cones of pre-
target axons, categorizing axons into groups that terminated in either
the ventral, mid or dorsal diencephalon. The expectation was that if
RGC axons were failing to navigate properly through the mid-
diencephalic turn, then there would be a noticeable concentration of
transgene-expressing growth cones in this region. Neither wtLIMK1-
nor kdLIMK1-expressing axons seemed to collect at the mid-
diencephalic turn (Fig. 6H), arguing that LIMK1 activity is required
for proper RGC axon extension but not guidance.
wtLIMK1 expression causes growth cone enlargement
Actin is the key structural support for the lamellipodia and
ﬁlopodia of the growth cone, and so misexpression of wt or kdLIMK1
may disrupt growth cone structure, as seen previously in culture
(Endo et al., 2003). Notably, once RGC axons enter the optic tectum
they branch and no longer have obvious growth cones. However, since
many of the wtLIMK1-, as well as some of the GFP- and kdLIMK1-,
expressing axons had not made it to the tectum at the time of ﬁxation,
the structure and size of their growth cones could be analyzed.
Interestingly, the growth cones at the tips of the wtLIMK1-expressing
axons within the optic tract were signiﬁcantly larger than those of
GFP- or kdLIMK1-expressing axons (Fig. 7; pb0.05, One Way ANOVA,Student–Newman–Keuls post hoc test). Growth cones with elevated
LIMK1 activity also tended to extendmore ﬁlopodia, but the difference
was not statistically signiﬁcant (Fig. 7; pN0.05; OneWay ANOVA). The
growth cones expressing kdLIMK1 were not signiﬁcantly different in
size or ﬁlopodia number from those expressing GFP.
BMPRII acts upstream of LIMK1 in axons
As LIMK1 appears to be important in mediating RGC axon
extension, we were interested in identifying a potential extrinsic
signal important for its activation. A BMP ligand was an intriguing
candidate signal for several reasons. First, LIMK1 binds to the
cytoplasmic tail of BMPRII, and can be activated through stimulation
of the receptor by BMP ligands (Foletta et al., 2003; Lee-Hoeﬂich et al.,
2004;Wen et al., 2007). Second, previous work in the lab showed that
in vivo expression of a truncated BMPRII, lacking the entire
intracellular portion including the serine/threonine kinase and
LIMK-binding domains, resulted in shorter RGC axons (unpublished
observation), a phenotype similar to that observed with overexpres-
sion of wtLIMK1. In support, we found that several BMPRII ligands are
expressed in the stage 35/36 brain neuroepithelium near the
developing optic tract (Fig. 8). First, bmp2 is expressed in the pineal
gland, below which retinal axons make their characteristic caudal-
wards turn, and in a spot in the mid-diencephalon (Fig. 8A). Second,
bmp4 and bmp7 are expressed near or in the pineal gland (Figs. 8B,
C), respectively. Finally, there is a large swath of bmp7 across the
ventral to mid-diencephalon and the telencephalon (Fig. 8C). The
axons of the optic tract travel in close proximity to this region of bmp7,
which is interesting because limk1 was shown to mediate BMP7-
induced attraction in spinal neurons (Wen et al., 2007). Since bmps
are expressed in brain regions neighboring the optic projection, we
next asked whether BMPs affect RGC axon extension. In support of an
in vivo role for BMPs in RGC axon extension, treatment of dissociated
stage 24 retinal cultures with 1 ng/ml BMP2 resulted in a signiﬁcant
increase (251.9 μm±31.1 μm (S.E.M.); n=3 independent experi-
ments; paired student t-test) in the length of RGC axons as compared
to control cultures (172.7 μm±13.3 μm).
To test whether BMPRII signals through LIMK1 in developing RGC
axons, we engineered a BMPRII construct that lacks the LIMK1-
binding region (BMPRIIΔLBR), similar to one used previously (Lee-
Hoeﬂich et al., 2004;Wen et al., 2007). The LBR is in the carboxy end of
the protein, and so could be removed without blocking kinase-
dependent activation of the Smad signalling pathway. We ﬁrst tested
whether BMPRIIΔLBR affected LIMK1 activity by determining if P-
coﬁlin1 levels were altered in RGCs expressing the BMPRIIΔLBR
transgene as compared to the GFP control. The retinas of stage 27
Xenopus embryos were electroporated with GFP either alone or with
myc-tagged BMPRIIΔLBR. Embryos were sacriﬁced 1 day later at stage
35/36 and 12 μm cryostat sections processed for P-coﬁlin1 immuno-
histochemistry. The intensities of the P-coﬁlin1 staining (0–3 bright-
ness scale) of GFP-positive RGCs were evaluated in a blinded fashion.
On average, BMPRIIΔLBR-expressing myc-positive RGCs exhibited half
the intensity of label (0.48±0.17, n=5 retinas, 83 cells) as GFP-
control RGCs (n=271 cells). We next investigated whether prevent-
ing LIMK1 from interacting with BMPRII impaired axon extension, as
would be predicted by the observations that BMP2 stimulates RGC
axon extension in vitro and kdLIMK1 inhibits RGC axon extension in
vivo. In three experiments, GFP was electroporated either alone or
with myc-tagged BMPRIIΔLBR into the retinas of stage 27 Xenopus
embryos. The embryos were grown to stage 39/40, ﬁxed and
processed for wholemount immunochemistry using anti-myc or
anti-GFP antibodies (Fig. 9). The location of the growth cone was
scored as being in the ventral, mid, or dorsal diencephalon, or at the
tectum.Manymore of the BMPRIIΔLBR-expressing RGC axons failed to
reach the tectum as compared to the GFP-expressing axons (Fig. 9;
pb0.05, paired Student's t-test). Notably, these embryos were slightly
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experiments (stage 39/40 versus stage 40), and so more of the GFP-
expressing axons were caught while still in transit to the target. In aseparate series of experiments, a wildtype BMPRII (wtBMPRII) was
electroporated as a control for the BMPRIIΔLBR. No signiﬁcant defect in
axon extension was observed, with similar numbers of wtBMPRII-
Fig. 7.wtLIMK1 overexpressing growth cones are larger than control. (A–C) Growth cones of transgene-expressing RGC axons labelled with α-GFP (A) or α-myc (B, C) antibodies in
stage 40 Xenopus brains. CS2-GFP, CS2-wtLIMK1-MTor CS2-kdLIMK1-MT was electroporated into the developing retinas of stage 27 embryos, which were ﬁxed at stage 40, dissected
and processed for wholemount immunochemistry. The growth cones photographed and analyzed are those that failed to reach the tectum. Scale bar in A is 10 μm for A–C. (D) Graph
showing the average area of the growth cones present at the tips of GFP, wtLIMK1-MT, or kdLIMK1-MT-expressing axons that fail to reach the tectum. n=the number of independent
experiments, and in brackets are the numbers of growth cones analyzed. Error bars are S.E.M. ⁎pb0.05, One Way ANOVA, Student–Newman–Keuls post hoc test. (E) Graph showing
the average number of ﬁlopodia extended from growth cones expressing wtLIMK1-MT, dnLIMK1-MT or GFP. n's are the same as for A. Error bars are S.E.M. There is no statistical
difference between the three groups. pN0.05, One Way ANOVA.
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expressing axons (GFP, 70.4%±6.9% (S.E.M.) of axons enter tectum,
n=4 independent experiments (636 axons); WTBMPRII, 63.3%±
11.6% (175 axons): pN0.05, paired Student's t-test).
As with wtLIMK1 overexpression, the growth cones of
BMPRIIΔLBR-expressing axons were found to be distributed at
random places along the optic tract, without an obvious stalling
point (Fig. 9F). The bias towards the ventral diencephalon likely
reﬂects the fact that these embryos were relatively young at the timeFig. 6. Altered LIMK1 activity prevents RGC axons from reaching their target. (A–F) Later
α-GFP (A, B) or α-myc antibodies (C–F). The developing retinas of stage 27 Xenopus embr
CS2-wtLIMK1-MT (C, D) or CS2-GFP plus CS2-kdLIMK1-MT (E, F). Embryos were ﬁxed at s
higher magniﬁcation views of the tracts shown in A, C, and E, respectively. (A, B) The vast ma
caudal turn in the mid-diencephalon (⁎) and innervated the optic tectum by stage 40 (dotte
axons expressing wtLIMK1-MT fail to reach their target by stage 40, and their growth cones
kdLIMK1-expressing axons also fail to reach the tectum (arrow; F). Scale bar in A is 50 μm fo
gland; P, Posterior; ot, optic tract; tec, tectum; tel, telencephalon; V, ventral. (G) Graph show
40. n=the number of independent experiments, and in brackets are the numbers of axons
post hoc test. (H) Graph showing the locations of the growth cones for the GFP, wtLIMK1-
ventral diencephalon, mid-diencephalon, or dorsal diencephalon, and then graphed as the
tectum, which were found in each region. n's are the same as in G.of analysis. In summary, these data suggest a connection between
BMP signalling and LIMK1 activation in promoting the extension of
RGC axons as they travel through the brain.
Discussion
Here we showed that the level of LIMK1 activity in Xenopus RGCs,
while likely not a major factor for dendrite formation, must be
carefully regulated to support proper axon outgrowth. Further, weal views of stage 40 wholemount Xenopus brains showing RGC axons labelled with
yos were electroporated with plasmids encoding CS2-GFP alone (A, B), CS2-GFP plus
tage 40 and their brains processed for wholemount immunochemistry. B, D, and F are
jority of RGC axons expressing GFP alone have grown through the diencephalon, made a
d line shows the approximate anterior border of the optic tectum). (C, D) Many of the
(arrows) can be detected at various locations within the optic tract. (E, F) Some of the
r A, C, E. Scale bar in B is 50 μm for B, D, F. A, anterior; D, dorsal; hb, hindbrain; pi, pineal
ing the percentage of transgene-expressing axons that fail to reach the tectum by stage
analyzed. Error bars are S.E.M. ⁎⁎⁎pb0.001, One Way ANOVA, Student–Newman–Keuls
MT or kdLIMK1-MT-expressing axons. Growth cones were categorized as being in the
percentage of the total number of expressing axons, including those that reached the
Fig. 8. BMP ligands are expressed near the developing optic tract. (A–C) Stage 35/36
wholemount brains processed for in situ hybridization using antisense probes to bmp2
(A), bmp4 (B), and bmp7 (C). All three mRNAs are expressed near or within the pineal
gland. bmp2 is also expressed in a spot in the mid-diencephalon (A), and bmp4 in a
stripe at the back of the tectum (B). bmp7 is expressed in a large area of the ventral
diencephalon and telencephalon (C). (D) Wholemount stage 40 Xenopus brain with
RGC axons labelled brown following GFP electroporation and anti-GFP immunochem-
istry. This shows the optic pathway for comparison to the bmp expression domains. The
dotted white line is at the approximate tectal border. A, anterior; D, dorsal; di,
diencephalon, mb, midbrain; oc, optic chiasm; pi, pineal gland; P, posterior; tec, tectum;
tel, telencephalon; V, ventral.
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growth cone of an extrinsic signal that regulates this ability of LIMK1
to control axon extension. Interestingly, BMP signalling promotes the
initiation of RGC dendrites (Hocking et al., 2008), as well as the
extension of axons from these same cells. However, the fact that
neither up- nor downregulation of LIMK1 activity altered dendrite
growth suggests that LIMK1may function downstream of BMP only in
the axon.
In our experiments, overexpression of wtLIMK1 and kdLIMK1
resulted in strong and weak defects in axonal extension, respectively.
The presence of myc-labelled growth cones indicates that the
shortened axon length was not due to a failure to label the distal
segments. Further, the presence of growth cones, coupled with the
lack of an effect of the LIMK1 constructs on dendrite formation, a
differentiation event that is initiated after RGC axons have extended
considerable distances in vivo, also argues against the likelihood that
the LIMK1 transgenic proteins indirectly inhibit axon extension by
making RGCs and their axons “sick”. Instead, we propose that normal
axon extension is sensitive to manipulation of LIMK1 activity.
Importantly, the difference in the severity of the kdLIMK1 and
wtLIMK1 axon extension phenotypes, and the fact that only the
wtLIMK1 transgene affected growth cone size, argues that the
mutation of the single amino acid in the kinase domain of the
LIMK1 results in a protein with quite different biological effects than
its wild type counterpart.
While overexpression of the wtLIMK1 protein upregulated LIMK1
function, as evidenced by an increase in the P-coﬁlin intensity ofwtLIMK1-expressing brain cells, the actions of the kdLIMK1 construct
are less clear. It caused no obvious change in P-coﬁlin levels, at least
within the cell body. The semi-quantitative assay we performed was
likely not sensitive at detecting small alterations in P-coﬁlin, so could
easily have missed changes in P-coﬁlin if kdLIMK1 is a weak inhibitor
of LIMK1 or is acting out in the growth cone. While often reported to
have weak effects on neuronal growth (Endo et al., 2003; Ng and Luo,
2004; Rosso et al., 2004; Takahashi et al., 2001), kdLIMK1 can also be
highly effective at blocking the effect of extrinsic molecules on growth
cones (Aizawa et al., 2001; Wen et al., 2007). Perhaps only in those
RGC growth cones with high kdLIMK1 expressionwas LIMK1 function
sufﬁciently affected to disturb axon extension. In support, the
observation that P-coﬁlin has a much broader expression pattern
than P-LIMK1 argues that cells have non-LIMK1 dependent mechan-
isms to regulate P-coﬁlin levels (Rosok et al., 1999; Toshima et al.,
2001a,b). The likelihood that the kdLIMK1 is indeed an inhibitor of
LIMK1 is supported by the fact that overexpression of wtSSH, which
similar to kdLIMK1 would result in P-coﬁlin dephosphorylation,
resulted in similar axon extension defects. This was also true of the
BMPRII construct missing the LBR. This domain was previously found
to be required for the induction of LIMK1 phosphorylation as a
consequence of BMP7 binding to the BMPRII receptor (Lee-Hoeﬂich et
al., 2004). Thus, three different methods to inhibit the effects of LIMK1
activity on P-coﬁlin levels all resulted in the same axon extension
defect. Importantly, slowed axon growth is not simply the result of
overexpression of proteins in RGC axons as evidenced by the fact that
the wtBMPRII had no effect on extension.
Thus, we propose a model whereby tight regulation of LIMK1
activity is required for proper axon extension (Fig. 9G). Both
upregulation and downregulation of LIMK1 function in the growth
cone would affect pathways important in maintaining a careful
balance of actin polymerization and depolymerization and continued
extension of the growth cone. Possibly, the weak effects of the
kdLIMK1 reﬂect that LIMK1 activity and associated coﬁlin inactivation
is already low in extending growth cones, given that increased coﬁlin
activity promotes axon extension (Endo et al., 2003; Meberg and
Bamburg, 2000; Sarmiere and Bamburg, 2004). The consequence of
excess LIMK1 activity is large and slowly extending RGC growth cones.
The fact that wtLIMK1- and GFP-expressing growth cones had similar
ﬁlopodial numbers, and LIMK1 overexpression in vitro can in some
cases result in longer axons (Rosso et al., 2004; Tursun et al., 2005),
suggest that an impaired cytoskeleton is not the explanation for the
large growth cones and axon extension defects observed for RGC
axons with high LIMK.
The importance of endogenous LIMK1 signalling in axonal growth
cones is supported by our observation that removal of extrinsic
regulation of the kinase, by eliminating the LBR of the BMPRII, results
in axon extension defects. We propose that LIMK activity is regulated
by the actions of one of the BMP ligands expressed in the brain, an idea
supported by our observation that BMP2 is biologically active for RGC
axons in vitro, and that when LIMK1 becomes dissociated from the
BMPR complex, axon extension is impaired (Fig. 9G). Two in vitro
studies show that LIMK1 is constitutively bound to BMPRII and that
treatment with a BMP ligand increases LIMK1 activity (Foletta et al.,
2003; Lee-Hoeﬂich et al., 2004). Therefore, the extension defect seen
with BMPRIIΔLBR-expressing axons should reﬂect a LIMK loss-of-
function phenotype. In support, BMPRΔLBR-expressing RGCs showed
reduced P-coﬁlin expression and kdLIMK1 gave a similar, albeit
weaker, extension phenotype.
A role for LIMK1 in vertebrate axon guidance had not been
addressed in vivo. No axon defects were reported in limkmutant mice,
though this does not appear to have been carefully investigated (Meng
et al., 2002, 2004). Certainly, changes in P-coﬁlin levels are observed
downstream of guidance cues applied to cultured growth cones
(Aizawa et al., 2001; Piper et al., 2006; Wen et al., 2007). Yet, while
wtLIMK1 affected P-coﬁlin levels in RGCs, we observed no obvious
Fig. 9. Blocking the interaction between BMPRII and LIMK1 disrupts RGC axon extension. (A–D) Lateral views of stage 40 wholemount Xenopus brains showing transgene-expressing RGC axons labelled in brownwith α-GFP (A, B) or α-myc
antibodies (C, D). The developing retinas of stage 27 Xenopus embryos were electroporated with plasmids encoding GFP alone (A, B) or GFP plus BMPRIIΔLBR-MT (C, D). Embryos were ﬁxed at stage 40 and their brains processed for
wholemount immunochemistry. B and D are higher magniﬁcation views of the tracts shown in A and C. The majority of RGC axons expressing GFP alone have grown through the diencephalon, made a caudal turn in the mid-diencephalon (⁎)
and innervated the optic tectum by stage 40 (dotted line shows the approximate anterior border of the optic tectum). Many of the axons expressing BMPRIIΔLBR-MT fail to reach their target by stage 40, and their growth cones (arrows) can be
detected at various locations within the optic tract. Scale bar in A is 50 μm for A, C. Scale bar in B is 50 μm for B, D. A, anterior; D, dorsal; hb, hindbrain; pi, pineal gland; P, Posterior; ot, optic tract; tec, tectum; tel, telencephalon; V, ventral. (E)
Graph showing the percentage of axons expressing either GFP or GFP/BMPRIIΔLBR that failed to reach the tectum at the time of ﬁxation. n=the number of independent experiments and in brackets are the numbers of axons analyzed. Error
bars are S.E.M. ⁎pb0.05, paired Student's t-test. (F) Graph showing the distribution of transgene-expressing growth cones along the optic pathway, averaged over three experiments. The numbers reﬂect the average percentage of total
transgene-expressing axons with growth cones in progressively more distal sections of the optic tract. n's are the same as in E. Error bars are S.E.M. (G) Schematic showing a proposed model for the pathways that act downstream of BMPR
signalling in RGC dendrites and axons. An unknown signalling pathway functions in dendrites, while the LIMK pathway is active in axons. Too much or too little LIMK activity changes the balance of actin polymerization–depolymerization
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extension of wtLIMK1-expressing axons were affected. Possibly the
large number of wildtype axons within the optic tract helped guide
the few transgene-expressing axons, or axons made small transient
guidance errors that might be seen if the axons were followed by
time-lapse microscopy. Alternatively, LIMK1/P-coﬁlin function in RGC
growth cones may be restricted to pathways, such as BMPRII
signalling, that impact axon extension and not guidance. The fact
that LIMK1 mediates the in vitro attraction of Xenopus spinal neurons
towards a BMP7 gradient (Wen et al., 2007), and LIMK1 RNAi loss-of-
function causes guidance defects of the axons of mushroom body
neurons in Drosophila (Ng and Luo, 2004) argue that at least in some
neurons LIMK1 is required for axon guidance.
XenopusRGCs express limk1mRNA at the time of dendrite initiation,
yet RGC dendritic arbor structure was unchanged by expression of
wtLIMK1orkdLIMK1. The constructs are functional, as both affected the
growth of RGC axons, wtLIMK1 overexpression upregulated P-coﬁlin
staining, and a non myc-tagged wtLIMK1 cDNAwas used previously to
delay the entry of Xenopus oocytes intomeiosis (Takahashi et al., 2001).
Moreover, we showedpreviously that a truncated BMPRII, missing both
the LBR as well as the kinase domain, affected RGC axon but not
dendrite development when expressed alone (Hocking et al., 2008).
Thus, it seemsmore likely that LIMK1 does not play a critical role in the
early stages of dendritogenesis. In agreement, mice mutant for limk1
produced hippocampal neurons with abnormal dendritic spines, but
normal overall dendriticmorphology (Meng et al., 2002). Thus, distinct
signal transduction mechanisms act in RGC axons and dendrites
downstream of BMPRII activation, with only axons relying on LIMK1-
dependent BMPRII-induced growth (Fig. 9G).
The importance of regulating LIMK1 activity is evident from its
association with disease states. Hemizygosity for LIMK1 is associated
with the impaired visuospatial cognition and mild mental retardation
seen in Williams syndrome (Hoogenraad et al., 2004), and limk1
mutant mice show behavioral abnormalities (Meng et al., 2002).
Increased LIMK1 activity is also detrimental. For instance, elevated P-
LIMK1 expression is associated with pathologies in Alzheimer's
disease (Heredia et al., 2006). Thus, LIMK1 activity must be regulated
at each stage during the development and maintenance of a properly
functioning nervous system. Understanding how it acts in different
subcellular compartments will be important in addressing LIMK1's
function in neuronal morphological differentiation in physiological
and pathophysiological states.
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